Business Context and Reporting Period
Company: Harvard Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: October 31, 2013
Reporting Period: The filing announces financial results for the three and nine months ended September 30, 2013.
Key Financial Metrics
The provided text is a cover sheet for a Form 8-K and does not contain specific financial data. It references a press release (Exhibit 99.1) for details on revenue, profit, cash flow, margins, debt, and liquidity. Consequently, the filing text does not provide a clear value for any specific financial metric.
Material Changes
The filing text does not disclose specific material changes versus prior periods. It serves only to notify the SEC of the issuance of a press release containing the results of operations and financial condition.
Guidance, Outlook, and Risks
Management Commentary: The filing incorporates by reference a press release issued on October 31, 2013, which contains the Company's results of operations and financial condition.
Legal Disclaimer: The information in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section, nor is it incorporated by reference in other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for actual revenue, net income, and cash flow figures for the periods ended September 30, 2013.
- Verify year-over-year and quarter-over-quarter performance trends in the referenced press release.
- Confirm any forward-looking statements or guidance provided in the press release, as they are not detailed in this 8-K summary.
- Note that the financial data in the referenced exhibit is not legally "filed" under Section 18 of the Exchange Act per the disclaimer in this document.